Catalyst Event
Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
5/13/2026, 12:00:00 AM
Subsidiary Fosun Pharma Industrial to sign an exclusive option agreement with AriBio for global licensing rights to Alzheimer's candidate AR1001; the strategic expansion is estimated to have a 1-5% price impact, expected.
Korean Translation
자회사 복성의약산업발전의 아리바이오 알츠하이머 치료제 AR1001 글로벌 권리 독점 옵션 계약 체결에 따른 완만한 주가 상승이 예상됨.
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
Cochlear Ltd (COH) · Earnings Release
Cochlear's full-year financial results for fiscal year 2026 are scheduled to be announced on August 18, 2026. Medium importance is estimated as annual earnings reports typically result in price movements exceeding 5%, scheduled.
8/18/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic to report Q4 and full fiscal year 2026 financial results, scheduled.
6/3/2026, 12:00:00 AM